Stereotactic ablative radiotherapy tops for inoperable early NSCLC
Australian and New Zealand research confirms what clinicians suspected
Staff Writer
22nd February 2019
Compared with standard radiotherapy, stereotactic ablative body radiotherapy (SABR) provides better local control and improved survival in patients with inoperable non-small-cell lung cancer (NSCLC), according to results of the CHISEL study.